Giant Cell Tumors
Giant cell tumor of bone is a rare, fast-growing noncancerous tumor. It most often develops in adults between the ages of 20 and 40, particularly after skeletal bone growth is complete. These tumors are slightly more common in women and typically grow near a joint at the end of a bone. Common locations include the knee, bones of the arms and legs, and occasionally flat bones such as the breastbone or pelvis.
Characteristics and Behavior
Giant cell tumors are aggressive despite being noncancerous. They often grow rapidly and can cause significant bone destruction. These tumors typically occur near joints, leading to symptoms that affect joint function. Due to their aggressive nature, giant cell tumors require prompt and often intensive treatment to prevent bone damage and preserve function.
Symptoms
Symptoms of giant cell tumors vary depending on their location. They may include a visible bump, bone fracture, fluid buildup in the nearby joint, limited movement in the nearest joint, swelling, and pain at the affected joint. If you experience any persistent or concerning symptoms, it is important to consult a healthcare provider for a diagnosis.
Causes
The exact cause of giant cell tumors is unknown. However, they have been linked to Paget disease of bone, a chronic condition that causes bones to become enlarged and misshapen.
Risk Factors
There are no identified risk factors for giant cell tumor of bone. It typically arises spontaneously in young adults, usually between the ages of 20 and 40.
Treatment Options
The primary goal in treating giant cell tumors is to remove the tumor and prevent bone damage. Treatment options may include:
- Surgery: To remove the tumor and any damaged bone.
- Bone Grafting: To repair bone defects after tumor removal.
- Bone Reconstruction: To restore the structure and function of the affected bone.
- Physical Therapy: To regain strength and mobility.
- Radiation Therapy: For tumors that cannot be surgically removed.
In severe cases, amputation may be necessary. Giant cell tumors can recur, so long-term follow-up with a healthcare provider is essential.